Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · December 10, 2013

No Survival Benefit With IV Immunoglobulin for Toxic Epidermal Necrolysis

The British Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
The Role of Intravenous Immunoglobulins in Toxic Epidermal Necrolysis: A Retrospective Analysis of 64 Patients Managed in a Specialized Centre
Br J Dermatol 2013 Dec 01;169(6)1304-1309, HY Lee, YL Lim, T Thirumoorthy, SM Pang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading